FyoniBio at HDDC – Helmholtz Drug Discovery Conference 2025

From April 28–30, FyoniBio GmbH, a Bio-PAT member, will join top scientists in Berlin to explore the latest in RNA therapeutics, AI-driven drug discovery, PROTACs, and more.
Meet the experts, Hans Baumeister and Dr. Christoph Goletz at their poster about “Quantification of oligonucleotide-based therapeutics in cerebrospinal fluid (CSF) and tissues using high-sensitive hybECLIA-based assays.”

The Helmholtz Drug Discovery Conference 2025 offers a premier platform to explore the challenges and opportunities shaping modern drug discovery.

This year’s event will delve into topics like:
• RNA therapeutics
• Novel cardiovascular drugs
• PROTACs
• AI-driven drug discovery
• Chemoproteomics

Featuring keynote talks from leading experts, as well as oral and poster presentations, HDDC2025 will foster innovation and collaboration. A dedicated session for start-ups provides an opportunity to showcase emerging research.

Set in Berlin—a hub for biotech and pharma—the conference promises an inspiring environment for groundbreaking discussions.

iCal exportieren